Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patients genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.
This report elaborates the market size, market characteristics, and market growth of the Precision Medicine Software industry, and breaks down according to the type, application, and consumption area of Precision Medicine Software. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Precision Medicine Software in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Precision Medicine Software market covered in Chapter 13:
Sanofi S.A
PierianDx, Inc
Syapse, Inc
Qiagen
Foundation Medicine, Inc
2bPrecise LLC
N-of-One, Inc
Flatiron Health, Inc
Abbott Laboratories
Pfizer, Inc
Human Longevity, Inc
Tempus Labs, Inc
GlaxoSmithKline plc
Translational Software, Inc
Gene42, Inc
Allscripts
Roper Technologies
NantHealth, Inc
Sunquest Information Systems Inc
LifeOmic Health, LLC
Koninklijke Philips N.V
Fabric Genomics
AstraZeneca plc
SOPHiA GENETICS SA
IBM Watson Group
Merck & Co., Inc

In Chapter 6, on the basis of types, the Precision Medicine Software market from 2015 to 2025 is primarily split into:
Cloud-based
On-premise

In Chapter 7, on the basis of applications, the Precision Medicine Software market from 2015 to 2025 covers:
Healthcare Providers
Research Centers & Government Institutes
Pharmaceutical & Biotechnology Companies
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025